Kajaria Ceramics Results Update

Kajaria Ceramics Capital Structure Change

Kajaria Ceramics will subscribe Rs 4.5 Crore of preference shares in step-down subsidiary Kerovit Global, improving its debt-equity ratio. The related party deal is at arm's length.

Value

₹4.50 Cr

Kajaria Ceramics Capital Structure Change

Kajaria Ceramics subscribed Rs 45 Crore of NCRPS in step-down subsidiary KGPL to improve its debt-equity ratio. KGPL remains a wholly-owned subsidiary; no entity is acquired.

Value

₹45.00 Cr

Kajaria Ceramics Earnings Call Transcript: Key Takeaways

Kajaria delivered solid volume growth and margin expansion despite subdued exports from Morbi. Management remains optimistic about double-digit volume growth driven by domestic demand and capacity expansions.

Call

Guides 10% growth

Kajaria Ceramics Capacity Expansion: ₹34 Cr Investment

Kajaria Ceramics will build a Rs.34 Crore tile adhesive plant in Durgapur, adding 9,000 MT monthly capacity. Completion is targeted by December 2027.

Value

₹34.00 Cr

Execution

Expected to be set up by December 2027

tile adhesive manufacturing capacity

9000.0 MT per month

Kajaria Ceramics Capacity Expansion: ₹340 Cr Investment

Kajaria Ceramics' board approved a 12.50 MSM per annum glazed vitrified tile capacity addition at ₹340 Crore. Completion is expected by June 2027, financed through internal accruals and debt.

Value

₹340.0 Cr

Execution

Expected to be completed by June 2027

glazed vitrified tile manufacturing capacity

12.5 MSM per annum

Kajaria Ceramics Capacity Expansion: ₹180 Cr Investment

Kajaria Ceramics' board approved an 11 MSM per annum tile capacity addition at an investment of ₹180 Crore. Completion is expected by April 2027, financed through internal accruals and debt.

Value

₹180.0 Cr

Execution

Expected to be completed by April 2027

tile manufacturing capacity

11.0 MSM per annum

Aatmaj Healthcare Results Update

Aatmaj Healthcare reported H1 FY27 revenue of Rs. 16.96 crore and EBITDA of Rs. 2.04 crore. The company targets 80% revenue growth for FY27.

RPG Life Sciences Results Update

RPG Life Sciences reported Q2 FY27 revenue of ₹211.6 crore, growing 16.5%, and adjusted EBITDA of ₹50.1 crore. The API business integration continues to progress.

Praruh Technologies Results Update

Praruh Technologies reported strong H1 FY27 growth, with revenue rising 378% YoY to ₹84.06 Crore and PAT increasing 733% to ₹8.18 Crore.

CARE Ratings Results Update

CARE Ratings reported strong Q2 and H1 FY27 operating income and profit growth. The board also declared an interim dividend of Rs 10 per share.

EPACK Durables Results Update

EPACK Durable reported record first-half revenue and strong Q2 FY27 growth. The board also approved exiting its EPAVO joint venture stake.

3i Infotech Results Update

3i Infotech reported Q2FY27 revenue of Rs.182.0 crore, up 4.1% year-on-year. Quarterly PAT stood at Rs.6.7 crore and 25 new client wins were added.